| Literature DB >> 31344959 |
Bandana Manandhar1, Aditi Wagle1, Su Hui Seong1, Pradeep Paudel1, Hyeung-Rak Kim1, Hyun Ah Jung2, Jae Sue Choi3.
Abstract
Compounds were isolated from Ecklonia stolonifera Okamura, a marine brown alga widely consumed as food. Among the isolated compounds, 974-A was demonstrated for the first time to be a potent competitive inhibitor of mushroom tyrosinase activity towards l-tyrosine and l-DOPA (IC50 values = 1.57 ± 0.08 and 3.56 ± 0.22 µM, respectively). Molecular docking simulations clarified that the hydroxyl residues of the isolated compounds formed hydrogen bonds with residues at the catalytic and allosteric sites of tyrosinase, while other residues participated in hydrophobic interactions. Moreover, 974-A, phlorofucofuroeckol-A and eckol reduced the cellular melanin content and tyrosinase activity, and downregulated the expression of melanogenesis enzymes including tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2 in B16F10 melanoma cells. These compounds also effectively scavenged radicals at the cellular level. Thus, our results revealed that compounds isolated from E. stolonifera are potent tyrosinase inhibitors with potential applications in the cosmetic industry for treatment of hyperpigmentation and for the anti-browning effect in the agricultural field.Entities:
Keywords: 974-A; Western blot analysis; antioxidant; molecular docking simulation; mushroom tyrosinase; phlorotannins
Year: 2019 PMID: 31344959 PMCID: PMC6720259 DOI: 10.3390/antiox8080240
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Structure of compounds isolated from Ecklonia stolonifera.
Mushroom tyrosinase inhibitory and free radical scavenging activity of phlorotannins isolated from E. stolonifera along with the kinetic analysis of 974-A.
| Compounds | IC50 Value | Type of inhibition 2, | |||||
|---|---|---|---|---|---|---|---|
| Mushroom Tyrosinase Inhibition | Radical Scavenging Activity | ||||||
| ONOO− | DPPH | ABTS•+ | |||||
| 974-A | 1.57 ± 0.08 | 3.56 ± 0.22 | 0.26 ± 0.06 | 0.92 ± 0.11 | 6.29 ± 0.34 | Competitive, 0.69 | Competitive, 3.33 |
| Phlorofucofuroeckol-A | 3.42 ± 0.01 | 8.14 ± 0.29 | 0.85 ± 0.10 | 1.92 ± 0.09 | 12.87 ± 0.95 | Non-competitive, 2.70 | Non-competitive, 7.14 |
| Eckol | 9.12 ± 0.36 | 29.59 ± 0.48 | 0.73 ± 0.07 | 1.63 ± 0.65 | 5.01 ± 0.19 | Non-competitive, 8.60 | Non-competitive, 28.47 |
| Phloroglucinol | 251.00 ± 5.52 | >400 | 1.72 ± 0.59 | >100 | 31.48 ± 1.68 | - | - |
| Arbutin 4 | 172.82 ± 4.70 | >500 | - | - | - | - | - |
| Kojic acid 4 | 7.82 ± 0.70 | 9.35 ± 0.70 | - | - | - | - | - |
| Penicillamine 4 | - | - | 1.07 ± 0.21 | - | - | - | - |
| Ascorbic acid 4 | - | - | - | 0.69 ± 0.04 | - | - | - |
| Trolox 4 | - | - | - | - | 18.40 ± 0.70 | - | - |
1 The 50% inhibition concentrations (IC50, µM) are expressed as the mean ± SD of triplicates. 2 Type of inhibition determined by Lineweaver-Burk plot. 3 Inhibition constant (K) determined by Dixon plot. 4 Positive controls.
Binding sites and docking scores of phlorotannins and reference compounds in oxy-form tyrosinase from Agaricus bisporus.
| Compounds | Binding Energy | No. of | H-Bond Interaction Residues | Hydrophobic Interacting Residues | Others |
|---|---|---|---|---|---|
| 974-A | −3.92 | 8 | Asp191, Ser282, His285, Met280, Asn260, Glu189, Tyr65 | Pi-Sigma: Val283, Pi-Pi T-shaped: Phe192, Phe264, Pi-Alkyl: Pro284, Val283, Pro284 | Electrostatic bond: His285, Glu189, van der Waals: Cu401 |
| Phlorofucofuroeckol-A | −8.79 | 8 | Tyr78, Asn81, Arg321, Ala246, His85, Lys79, Ala323, Tyr65 | Pi-Sigma: Ala80, Pi-Pi T-shaped: His85, Pi-Alkyl: Arg321 | Electrostatic bond: His244, Glu322 |
| Eckol | −6.29 | 6 | His85, Cys83, Glu322, Tyr65, Ala323, Lys79 | Pi-Sigma: Ala80, Pi-Alkyl: Pro284 | - |
| Phloroglucinol | −4.87 | 5 | Arg321, Gly86, Glu239, Val88, Met319 | - | - |
| −6.31 | 5 | His244, Asn260, Met280, Glu256 (Salt-bridge) | Pi-Alkyl: Ala286, Pi-Sigma: Val283, Pi-Pi Stacked: His263 | van der Waals: Cu401, Cu400, Per402 | |
| Luteolin 1 | −6.19 | 4 | Cys83, Gly245, Ala246, Val248 | Pi-Alkyl: Val248, Pi-Sigma: His85 | Electrostatic bond: Glu322 |
1l-Tyrosine and luteolin are used as positive control as competitive and allosteric inhibitor, respectively.
Figure 2(I) Top binding mode of phlorotannins phloroglucinol (blue stick), eckol (green stick), phlorofucofuroeckol-A (purple stick), and 974-A (yellow stick) for the oxy-form tyrosinase with positive controls, l-tyrosine (black stick) and luteolin (red stick) (A). Copper and peroxide ions are shown in orange and red spheres, respectively. (II) 2D diagram showing l-tyrosine (A), luteolin (B), phloroglucinol (C), eckol (D), phlorofucofuroeckol-A (E), and 974-A (F) binding pose in active site of tyrosinase.
Figure 3Effects of various concentrations of 974-A (A,D), phlorofucofuroeckol-A (PFF-A) (B,E), and eckol (C,F) on the melanin content and tyrosinase activity, respectively, of α-MSH treated B16F10 melanoma cells. Cells were pretreated with the indicated concentrations (6.25, 12.5, 25, 50, and 100 μM) of 974-A, PFF-A, and eckol for 1h followed by exposure to α-MSH (3.0 μM) for 24h in the presence or absence of the test compound. Arbutin (500 μM) was used as a positive control. Data represent the mean ± SD of three independent experiments. a p < 0.01 indicates significant differences from the normal control group (no treatment); b p < 0.05, c p < 0.01, and d p < 0.001 indicate significant differences from the α-MSH treated group.
Figure 4Effect of different concentrations of 974-A (A), phlorofucofuroeckol-A (PFF-A) (B), and eckol (C) on tyrosinase (TYR), tyrosinase related protein-1 (TRP-1), and TRP-2 expression level in α-MSH. Cells were pretreated with the indicated concentration of 974-A, phlorofucofuroeckol-A (PFF-A), eckol along with α-MSH and arbutin for 24 h. Western blotting was performed and protein band intensities were quantified by densitometric analysis using CS analyzer Eng software. Upper panels display representative blots. Equal protein loading was ensured and normalized against β-actin levels. Data represent the mean ± SD of three independent experiments. a p < 0.01 indicates significant differences from the normal control group (no treatment); b p < 0.05, c p < 0.01, and d p < 0.001 indicate significant differences from the α-MSH treated group.
Figure 5Effect of different concentrations of 974-A, eckol and phlorofucofuroeckol-A (PFF-A) on intracellular reactive oxygen species (ROS) levels in tert-butyl hydroperoxide (t-BHP) treated B16F10 melanoma cells. Cells were pretreated with the indicated concentration of 974-A, phlorofucofuroeckol-A, eckol along with t-BHP (400 µm) and trolox for 2 h, and then with 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) (25 µM) for 30 min to induce ROS generation. Data represent the mean ± SD of three independent experiments. a p < 0.01 indicates significant differences from the normal control group (no treatment); b p < 0.05, c p < 0.01, and d p < 0.001 indicate significant differences from the alpha-melanocyte-stimulating hormone (α-MSH) treated group.